RB
CVS icon

Renasant Bank’s CVS Health CVS Stock Holding History

Renasant Bank’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,122
Closed -$423K – 182
2023
Q2 		$423K Sell
6,122
-3,917
-39% -$279K 0.35% 95
2023
Q1 		$746K Sell
10,039
-464
-4% -$38.9K 0.58% 53
2022
Q4 		$979K Buy
10,503
+1,188
+13% +$115K 0.74% 42
2022
Q3 		$888K Sell
9,315
-288
-3% -$28.5K 0.78% 38
2022
Q2 		$890K Sell
9,603
-1,532
-14% -$150K 0.73% 43
2022
Q1 		$1.13M Buy
11,135
+335
+3% +$35.2K 0.76% 35
2021
Q4 		$1.11M Buy
10,800
+710
+7% +$65.6K 0.76% 34
2021
Q3 		$856K Buy
10,090
+106
+1% +$8.88K 0.68% 40
2021
Q2 		$833K Buy
9,984
+3,598
+56% +$295K 0.63% 50
2021
Q1 		$480K Sell
6,386
-1,525
-19% -$111K 0.39% 83
2020
Q4 		$541K Buy
+7,911
New +$515K 0.44% 66

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renasant Bank's CVS Position: Q3 2023 in Review

Renasant Bank sold out of CVS Health (CVS) in Q3 2023, closing a stake of 6,122 shares — an estimated $423K sold.

Renasant Bank first reported a position in CVS in Q4 2020 and held it in 11 quarters. The position peaked at $1.13M in Q1 2022. 2,114 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Renasant Bank reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • Renasant Bank sold 6,122 CVS Health shares in Q3 2023, an estimated $423K.
  • Renasant Bank first reported a position in CVS Health in Q4 2020 and held it in 11 quarters.
  • Renasant Bank's CVS Health position peaked at $1.13M in Q1 2022.
  • 2,114 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Renasant Bank's 13F filing for Q3 2023, filed 1 Nov 2023.